Literature DB >> 26620839

Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.

Eric Wiesen1, William Lagani2, Gerard Sui2, Johnnie Arava2, Salim Reza3, Sergey Diorditsa1, Yung-Ching Lin4.   

Abstract

INTRODUCTION: Papua New Guinea (PNG) implemented hepatitis B birth dose (BD) vaccination in 2005 yet since that time coverage has remained low, allowing mother-to-child transmission to occur. We conducted a field assessment of the BD vaccination program to develop strategies for improving the BD coverage.
METHODS: We selected five provinces with higher hepatitis B prevalence and five with lower prevalence based on the results of a 2013 hepatitis B serological survey. Within each province, we interviewed district and provincial health officers, health workers, village volunteers, and caregivers from ten randomly selected health facilities. Data were collected on knowledge, practice, vaccine management and data recording/reporting. To identify enabling factors and barriers, we compared health facilities with higher BD coverage with those with lower coverage, and compared caregivers whose children received BD with those whose children did not.
RESULTS: Overall timely BD coverage was 31% and BD vaccination was taking place in 81% of sampled health facilities. Lack of cold chain and vaccine were the major reasons for not providing the BD. Insufficiencies in supervision, vaccine management, community outreach, and data management were identified as obstacles to achieving high timely hepatitis B BD coverage. Good supervision, knowledge of hepatitis B and hepatitis B vaccination, antenatal care including information about the hepatitis B BD, provision of vaccine refrigerators in maternity wards, and outreach vaccination for home deliveries were associated with higher timely BD coverage. DISCUSSION: Several steps will likely be effective in improving BD coverage: strengthening training and supervision among health workers and officers, educating caregivers on the benefits of the BD and delivery in health facilities, improving vaccine management, and improving data quality. Considerable effort and leadership will be needed to achieve these steps.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Caregivers; Health facilities; Health knowledge, attitudes, practice; Hepatitis B vaccines; Home childbirth; Immunization program; Papua New Guinea

Mesh:

Substances:

Year:  2015        PMID: 26620839     DOI: 10.1016/j.vaccine.2015.11.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.

Authors:  Jodie Dionne-Odom; Andrew O Westfall; Divine Nzuobontane; Michael J Vinikoor; Gregory Halle-Ekane; Thomas Welty; Alan T N Tita
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129

Review 2.  Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities.

Authors:  Jodie Dionne-Odom; Basile Njei; Alan T N Tita
Journal:  Clin Ther       Date:  2018-07-05       Impact factor: 3.393

Review 3.  Implementation Approaches for Introducing and Overcoming Barriers to Hepatitis B Birth-Dose Vaccine in sub-Saharan Africa.

Authors:  Alix Boisson; Varun Goel; Marcel Yotebieng; Jonathan B Parr; Bruce Fried; Peyton Thompson
Journal:  Glob Health Sci Pract       Date:  2022-02-28

4.  Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea.

Authors:  Alice Unah Lee; Luke Mair; Bob Kevin; Lily Gandi; Olive Tarumuri; Caroline Lee; Sue Huntley; David Carl Hilmers
Journal:  Western Pac Surveill Response J       Date:  2020-12-16

5.  High Prevalence of Chlamydia and Gonorrhea and the Need for Sexually Transmitted Infection Testing Among Men Who Have Sex With Men and Transgender Women in Papua New Guinea.

Authors:  Avi J Hakim; Chelsea Iwamoto; Steven G Badman; Barne Willie; Simon Pekon; Herick Aeno; Ruthy Neo-Boli; Sophie Ase; Damian Weikum; Andrew J Vallely; Angela Kelly-Hanku
Journal:  Sex Transm Dis       Date:  2021-02-01       Impact factor: 3.868

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.